Banque Cantonale Vaudoise »

Structure Therapeutics shares owned by Banque Cantonale Vaudoise

Quarter-by-quarter ownership of Structure Therapeutics (GPCR) shares owned by Banque Cantonale Vaudoise from 13F filings

Historical chart of Banque Cantonale Vaudoise investment in Structure Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Structure Therapeutics held by Banque Cantonale Vaudoise consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Structure Therapeutics by Banque Cantonale Vaudoise

Quarter filed Position value Share count Share price at filing
2025-12-31 $205k 2.9k 69.61

More positions owned by Banque Cantonale Vaudoise

Ubs Group SHS (UBS)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alcon Ord Shs (ALC)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Amazon (AMZN)
Visa Com Cl A (V)
Amrize SHS (AMRZ)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Logitech Intl S A SHS (LOGI)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)

View all positions for Banque Cantonale Vaudoise

Top funds holding Structure Therapeutics

venBio Select Advisor
Wellington Management Company
FMR
Henderson Group
Deep Track Capital
BVF
Baker Bros. Advisors
RA Capital Management
Principal Financial Group
Millennium Management
Casdin Capital
OrbiMed Advisors
Siren
TCG Crossover Management
Driehaus Capital Management

View all funds holding Structure Therapeutics